Xenon Pharmaceuticals Inc.

Rachunek Zysków i Strat


Profil spółki
Statystyki
Dywidendy
Rekomendacje
Wyceny
Wskaźniki
Analiza techniczna



Przychody TTM (mln): 5
EBIT TTM (mln): -256
index 0 1 2 3 4 5 6 7 8 9 10 11 12 13
Rok finansowy 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 7 14 27 28 16 2 0 0 7 32 18 9 0 0
Przychód Δ r/r 0.0% 106.8% 91.2% 3.7% -45.1% -88.4% -82.8% -100.0% inf% 371.0% -42.7% -48.8% -100.0% 0.0%
Marża brutto 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% -inf% -468.8% -57.1% -309.3% -1021.1% -inf% 0.0%
EBIT (mln) -12 -3 10 11 -9 -25 -33 -38 -43 -31 -79 -129 -214 -279
EBIT Δ r/r 0.0% -74.0% -408.0% 14.4% -184.3% 165.1% 31.3% 16.7% 12.6% -26.9% 152.4% 63.5% 65.7% 30.5%
EBIT (%) -175.1% -22.0% 35.5% 39.1% -60.1% -1376.4% -10474.3% 0.0% -627.0% -97.3% -428.4% -1368.9% 0.0% 0.0%
Koszty finansowe (mln) 0 0 0 0 0 0 0 1 1 0 0 -6 0 0
EBITDA (mln) -11 -2 11 12 -9 -25 -33 -36 -40 -31 -79 -129 -211 -279
EBITDA(%) -156.5% -15.5% 39.3% 43.8% -60.1% -1401.5% -10713.8% 0.0% -586.3% -97.3% -428.4% -1368.9% 0.0% 0.0%
Podatek (mln) 0 0 0 0 -1 -2 -2 5 -0 -0 -0 0 -0 4
Zysk Netto (mln) -12 -4 12 13 -16 -23 -31 -34 -42 -29 -79 -125 -182 -234
Zysk netto Δ r/r 0.0% -64.1% -379.7% 8.2% -221.0% 46.0% 33.5% 12.4% 20.6% -30.7% 173.5% 58.9% 45.5% 28.5%
Zysk netto (%) -173.3% -30.1% 44.0% 45.9% -101.1% -1275.5% -9872.7% 0.0% -609.1% -89.7% -427.8% -1328.9% 0.0% 0.0%
EPS -1.32 -0.47 0.42 4.11 -1.1 -1.48 -1.71 -1.78 -1.6 -0.83 -1.81 -2.07 -2.73 -3.01
EPS (rozwodnione) -1.23 -0.44 0.39 3.28 -1.1 -1.48 -1.71 -1.78 -1.6 -0.83 -1.81 -2.07 -2.73 -3.01
Ilośc akcji (mln) 9 9 9 3 14 15 18 19 26 35 44 61 67 78
Ważona ilośc akcji (mln) 10 10 10 4 14 15 18 19 26 35 44 61 67 78
Waluta USD USD USD USD USD USD USD USD USD USD USD USD USD USD